Patents by Inventor Mandar Bodas

Mandar Bodas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9834542
    Abstract: The present invention provides compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXR), compositions comprising any of such novel compounds, methods of using these compounds or compositions as medicaments for prevention or treatment of diseases or disorders related to liver X receptor (LXR), as well as methods of preparing these LXR modulators and using them in the manufacture of medicaments.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 5, 2017
    Assignees: Bristo-Myers Squibb Company, Exelixis Patent Company LLC
    Inventors: Ellen K. Kick, Mandar Bodas, Raju Mohan, Meriah Valente, Nicholas Wurtz, Sharanabasappa Patil
  • Patent number: 9751869
    Abstract: The present invention provides compounds of Formula I and Formula II: or pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXRs), and compositions comprising any of such novel compounds and methods of use thereof. These compounds are useful as medicaments for treatment and/or prophylaxis for diseases or conditions related to activity of LXRs.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: September 5, 2017
    Assignees: Bristol-Myers Squibb Company, Exelixis Patent Company LLC
    Inventors: Ellen K. Kick, Mandar Bodas, Raju Mohan, Brett B. Busch, Claudia Averbuj, Meriah Valente, Nicholas Wurtz, Prasanna Savanor Maddu Rao, Jeevanprakash Shetty, Alla Venu
  • Publication number: 20160304499
    Abstract: The present invention provides compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXR), compositions comprising any of such novel compounds, methods of using these compounds or compositions as medicaments for prevention or treatment of diseases or disorders related to liver X receptor (LXR), as well as methods of preparing these LXR modulators and using them in the manufacture of medicaments.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 20, 2016
    Applicants: BRISTOL-MYERS SQUIBB COMPANY, EXELIXIS PATENT COMPANY LLC
    Inventors: Ellen K. Kick, Mandar Bodas, Raju Mohan, Meriah Valente, Nicholas Wurtz, Sharanabasappa Patil
  • Publication number: 20160289222
    Abstract: The present invention provides compounds of Formula I and Formula II: or pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXRs), and compositions comprising any of such novel compounds and methods of use thereof. These compounds are useful as medicaments for treatment and/or prophylaxis for diseases or conditions related to activity of LXRs.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 6, 2016
    Applicants: BRISTOL-MYERS SQUIBB COMPANY, EXELIXIS PATENT COMPANY LLC
    Inventors: Ellen K. Kick, Mandar Bodas, Raju Mohan, Brett B. Busch, Claudia Averbuj, Meriah Valente, Nicholas Wurtz, Prasanna Savanor Maddu Rao, Jeevanprakash Shetty, Alla Venu